WallStreet Performers of the Day: Axcelis Technologies Inc. (NASDAQ:ACLS), Protalix BioTherapeutics, Inc. (NYSE:PLX)

Axcelis Technologies Inc. (NASDAQ:ACLS)

The shares of Axcelis Technologies Inc. (NASDAQ:ACLS) started off the last trading session with the price of $27.5 while closing the day with the price of $26.8. The shares of Axcelis Technologies Inc. (NASDAQ:ACLS) Fell -0.19% with the Loss of -0.7 points.

The shares of Axcelis Technologies Inc. (NASDAQ:ACLS) traded with the day volume of 633571 shares whereas its average trading volume is 468.75 Million.

While analyzing the past performance of the stock we can see that the shares of Axcelis Technologies Inc. (NASDAQ:ACLS) Gain 8.72% in the last week while rising 19.38% in the last month. Past quarter performance shows the red light with -12.42%. The semi-annual and annual performance shows 24.65% and 80.47% respectively.

Some critical values of the shares of Axcelis Technologies Inc. (NASDAQ:ACLS) to be discussed here are: the beta which shows the value at 1.03 while Average True Range of Axcelis Technologies Inc. (NASDAQ:ACLS) demonstrate the value at 1.16. The weekly and monthly volatility of the shares of Axcelis Technologies Inc. (NASDAQ:ACLS) are indicated at 4.18% and 4.10%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 57.17.

While studying the financial position of the shares of Axcelis Technologies Inc. (NASDAQ:ACLS), we can see that the Market capitalization of the company is at 817.4 Million. The shares outstanding for the company is 30.5 Million and the shares float stands at 30.5 Million. The income of the company stand at 128 Million while the sales stand at 410.6 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 3.78, Price to Earnings or P/E is at 7.09, Price to Sales P/S show the value of 1.99, the Return on Asset ROA stood at 0.087 and the Return on Equity ROE depicted at 0.13 while Return on Investment ROI is at 0.067.


Protalix BioTherapeutics, Inc. (NYSE:PLX)

Protalix BioTherapeutics, Inc. (NYSE:PLX) started its previous trading session at $0.68 and closed at $0.67 showing a Fell of -2.9 Percent.

The Company traded with an average Volume of 817.03 Million whereas, its Day Volume stood at 777133.

Looking at the performance of the stock, Protalix BioTherapeutics, Inc. (NYSE:PLX) Loss -2.1% in the last week in its shares price and 3.36% in the last month. Quarterly performance shows a green of 3.38 Percent while Semi-Annual and Annual performances shows a 8.06 and -43.22 percent respectively.

Beta for Protalix BioTherapeutics, Inc. (NYSE:PLX) stands at 0 while the ATR (average true range) is at 0.03. The Stock’s Weekly and Monthly Volatility is 5.41% and 4.93% respectively showing a RSI value of 49.12.

While studying the financial position of the shares of Protalix BioTherapeutics, Inc. (NYSE:PLX), we can see that the Market capitalization of the company is at 97.53 Million. The shares outstanding for the company is 145.57 Million and the shares float stands at 130.34 Million.

The Company generated an income of 0 and the sales of 18.85 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.59 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 5.17 respectively.

The Return on Assets stands at 0, ROE shows a value of 0 and ROI for Protalix BioTherapeutics, Inc. (NYSE:PLX) is 0 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment